Tim Doyle (@_timdoyle) 's Twitter Profile
Tim Doyle

@_timdoyle

Founder @ Eucalyptus.vc: home to pilot.com.au, kinfertility.com.au, myjuniper.com & skin.software

ID: 4118441592

linkhttp://www.eucalyptus.vc calendar_today04-11-2015 00:52:20

2,2K Tweet

2,2K Followers

1,1K Following

Eric Topol (@erictopol) 's Twitter Profile Photo

New NEJM A GLP-1 drug (semaglutide) led to lack of need for insulin in 7 of 10 people with recent onset Type 1 (autoimmune) diabetes, and the other 3 of 10 had eliminated need for insulin w/ meals nejm.org/doi/full/10.10…

New <a href="/NEJM/">NEJM</a>
A GLP-1 drug (semaglutide) led to lack of need for insulin in 7 of 10 people with recent onset Type 1 (autoimmune) diabetes, and the other 3 of 10 had eliminated need for insulin w/ meals
nejm.org/doi/full/10.10…
Tim Doyle (@_timdoyle) 's Twitter Profile Photo

This is nicely articulated. You needy hype oriented stuff for Instagram and then basics for consistency. In Australia the Messina marketing model.

This is nicely articulated. You needy hype oriented stuff for Instagram and then basics for consistency. In Australia the Messina marketing model.
Ben Thompson (@benthompson) 's Twitter Profile Photo

Back in 2016 I made the case that the problematic impact of fake news was ultimately a function of who delivered it, and that to focus on social media was a red herring. Seems pertinent. stratechery.com/2016/fake-news/

Back in 2016 I made the case that the problematic impact of fake news was ultimately a function of who delivered it, and that to focus on social media was a red herring. Seems pertinent.

stratechery.com/2016/fake-news/
Tim Doyle (@_timdoyle) 's Twitter Profile Photo

I'm looking for an accountant who will actually handle all of my accounting related work. Company set ups, angel investing, advisory agreements, structuring. Does this exist? Any recommendations?

Z Reitano (@zreitano) 's Twitter Profile Photo

GLP1s are inevitable. Delaying coverage can be the single largest accelerant of health inequity in our lifetime and increasing it the most powerful tool to bridge the gap. ro.co/weight-loss/gl…

Tim Doyle (@_timdoyle) 's Twitter Profile Photo

Agree with this, but it’s a bit skewed to US conditions where labour is cheap and ingredients are relatively expensive, you see slightly different patterns in Australia (more Asian, more ingredient oriented modern Australian, less French)

scott belsky (@scottbelsky) 's Twitter Profile Photo

only when you’re personally involved with any piece of “news” do you realize just how off most hot takes really are, and just how much nuance, in aggregate, changes everything.

Tim Doyle (@_timdoyle) 's Twitter Profile Photo

We've launched compound.co A lot of hype around longevity atm. My belief is that giving you information about your health is not going to be an interesting business. It will be the clinics that remove the friction from good health decisions that will win.

Tim Doyle (@_timdoyle) 's Twitter Profile Photo

A frustrating aspect of how Aus media covers Canva is that it is so focused on the founding story and the val. You never see a decent write up of the product and operational marvel that is building something that grows 40% YoY at 2B rev. It's one of the best we've ever produced.

Tim Doyle (@_timdoyle) 's Twitter Profile Photo

I love that Wework offices are a time capsule for the cringiest era in startup history. The rise and fall of the hustle porn infantilised optimism era of 2016-1019 is just so perfectly encapsulated by my Wework cup that hasn't been replaced once and says "glass half full" on it.

Tim Doyle (@_timdoyle) 's Twitter Profile Photo

The single stupidest concept in all of marketing (in a strong field) is that "brand" is a channel or a content format. The endless, ridiculous back and forth between brand and performance marketers is so dumb Tell engaging stories in places where your audience pays attention

Dr. Spencer Nadolsky (@drnadolsky) 's Twitter Profile Photo

Tirzepatide keeps weight off for 172 weeks (over 3 years). These aren’t short term bandaids. They are long term / chronic therapies for obesity. investor.lilly.com/news-releases/…